ABOUT U-73122

Compound sixty has an exceedingly high affinity to MDM2 (Ki < 1 nM), potent cellular activity, and a very good oral pharmacokinetic profile. Compound sixty is capable of reaching total and extensive-Long lasting tumor regression in vivo and is also at present in phase I medical trials for cancer treatment.BACKGROUNDDormant chemotherapy-resistant le